jain.com

Contingent payment obligations to noteholders

Company: Core Scientific

Subject kind
financing
Statement date
2024-01-24
Promised amount
130000000.0 USD
Current status
stated

The claim, verbatim

If the new shares trade below plan equity value, convertible noteholders are eligible for up to $130 million in cash or stock over 3 years, up to about $43 million per year.

Source (primary)

core-scientific 8-K exhibit (d735123dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-13)Live source ↗

Quote: “up to $130 million of potential Contingent Payment Obligations to the convertible noteholders (up to ~$43 million per year for 3 years)”

How we checked this

Checked on November 14, 2026. The cited source supports every part of this claim.

The document says that if the new shares trade below Plan Equity Value, convertible noteholders are eligible for up to $130 million in cash or stock over 3 years. It also describes these as Contingent Payment Obligations of up to about $43 million per year for 3 years.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/d735123dex992.htm) in full (29,831 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms core-scientific 8-K exhibit (d735123dex992.htm)

Quote: “up to $130 million of potential Contingent Payment Obligations to the convertible noteholders (up to ~$43 million per year for 3 years)”

View cached copy (2026-11-13)Live source ↗